Cryo Cell International (CCEL) Long-Term Deferred Tax (2010 - 2026)

Cryo Cell International (CCEL) has 15 years of Long-Term Deferred Tax data on file, last reported at $23.6 million in Q1 2026.

• Long-Term Deferred Tax for Q1 2026 came in at $23.6 million, up 13.55% year-over-year; the trailing twelve-month figure through Feb 2026 was $23.6 million (up 13.55% YoY), and the FY2025 annual result was $23.6 million, up 13.55% from the prior year.
• Long-Term Deferred Tax held at $23.6 million in Q1 2026 per CCEL's latest filing, from $23.6 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $23.6 million in Q4 2025 and troughed at $12.0 million in Q1 2022.
• A 5-year average of $17.8 million and a median of $20.5 million in 2023 frame the typical range for Long-Term Deferred Tax.
• The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax jumped 49.12% in 2023, then increased 1.51% in 2024.
• A 5-year view of Long-Term Deferred Tax shows it stood at $13.7 million in 2022, then surged by 49.12% to $20.5 million in 2023, then grew by 1.51% to $20.8 million in 2024, then grew by 13.55% to $23.6 million in 2025, then changed by 0.0% to $23.6 million in 2026.
• Business Quant data shows CCEL's Long-Term Deferred Tax at $23.6 million in Q1 2026, $23.6 million in Q4 2025, and $20.8 million in Q3 2025.